Sociodemographic and Lifestyle Determinants of Plasma Oxidative Stress Markers 8-OHdG and F2-Isoprostanes and Associations with Metabolic Syndrome

Background. Oxidative stress is increasingly important in health research. Therefore, it is necessary to understand which factors determine basal oxidative stress. This study examines the associations of various determinants with markers of oxidative DNA and lipid damage: 8-hydroxy-2′-deoxyguanosine (8-OHdG) and F2-isoprostanes. Methods. Data are from the Netherlands Study of Depression and Anxiety; 1117 subjects (18–65 years) without a current psychiatric diagnosis. Multivariable regression analyses were conducted with plasma levels of 8-OHdG and F2-isoprostanes (measured by LC/MS-MS) including sociodemographic, lifestyle, and sampling variables. Associations with metabolic syndrome (MetS) and chronic disease were examined. Results. 8-OHdG and F2-isoprostanes were weakly correlated (r = 0.06, p = 0.045). Both were positively associated with age and cotinine (cigarette exposure); 8-OHdG was lower in females and after longer sample storage. F2-isoprostanes were higher in females, alcohol users, and in samples collected in spring and lower in supplement users and those with more education. Both markers were lower in fasting subjects. F2-isoprostanes, not 8-OHdG, were positively associated with MetS. Conclusion. The weak correlation between 8-OHdG and F2-isoprostanes suggests they reflect specific aspects of oxidative stress. Both markers are associated with a range of sociodemographic, lifestyle, and sampling determinants which should be considered in future research. F2-isoprostanes are associated with MetS.

[1]  P. Cuijpers,et al.  Is depression associated with increased oxidative stress? A systematic review and meta-analysis , 2015, Psychoneuroendocrinology.

[2]  P. Scheffer,et al.  8-Hydroxy-2′-Deoxyguanosine and Cardiovascular Disease: a Systematic Review , 2014, Current Atherosclerosis Reports.

[3]  Da‐hong Wang,et al.  Comparison of serum ferritin and oxidative stress biomarkers between Japanese workers with and without metabolic syndrome. , 2014, Obesity research & clinical practice.

[4]  N. Rothman,et al.  Nonexercise physical activity and inflammatory and oxidative stress markers in women. , 2014, Journal of women's health.

[5]  M. Buchowski,et al.  The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth , 2014, Pediatric obesity.

[6]  E. Niki.  Biomarkers of lipid peroxidation in clinical material. , 2014, Biochimica et biophysica acta.

[7]  Zhi-Jiang Zhang.  Systematic review on the association between F2-isoprostanes and cardiovascular disease , 2013, Annals of clinical biochemistry.

[8]  M. Evans,et al.  Markers of oxidant stress that are clinically relevant in aging and age-related disease , 2013, Mechanisms of Ageing and Development.

[9]  D. Nieman,et al.  Inflammation and oxidative stress are lower in physically fit and active adults , 2013, Scandinavian journal of medicine & science in sports.

[10]  L. Wagenknecht,et al.  Urinary F2‐Isoprostanes, Obesity, and Weight Gain in the IRAS Cohort , 2012, Obesity.

[11]  N. Suganuma,et al.  Assessment of lifestyle effect on oxidative stress biomarkers in free‐living elderly in rural Japan , 2012, Geriatrics & gerontology international.

[12]  G. Egeland,et al.  Isoprostanes and isofurans as non-traditional risk factors for cardiovascular disease among Canadian Inuit , 2012, Free radical research.

[13]  S. Selek,et al.  No effect of antidepressant treatment on elevated serum ceruloplasmin level in patients with first-episode depression: a longitudinal study. , 2012, Archives of medical research.

[14]  B. Halliwell,et al.  Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? , 2011, Free radical biology & medicine.

[15]  P. Poulsen,et al.  Genetic and environmental influences on oxidative damage assessed in elderly Danish twins. , 2011, Free radical biology & medicine.

[16]  L. Roberts,et al.  F2-isoprostanes as an indicator and risk factor for coronary heart disease. , 2011, Free radical biology & medicine.

[17]  K. Kotani,et al.  The Relationship between Urinary 8-Hydroxydeoxyguanosine and Metabolic Risk Factors in Asymptomatic Subjects , 2011, Medical Principles and Practice.

[18]  K. Costa,et al.  Comparison of three oxidative stress biomarkers in a sample of healthy adults , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[19]  Yueqin Kong,et al.  Oxidative stress as a mediator of cardiovascular disease , 2009, Oxidative medicine and cellular longevity.

[20]  K. Matthews,et al.  Socioeconomic Status, Antioxidant Micronutrients, and Correlates of Oxidative Damage: The Coronary Artery Risk Development in Young Adults (CARDIA) Study , 2009, Psychosomatic medicine.

[21]  A. Valavanidis,et al.  8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis , 2009, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.

[22]  Da‐hong Wang,et al.  Oxidative Stress Biomarkers and Lifestyles in Japanese Healthy People , 2009, Journal of clinical biochemistry and nutrition.

[23]  L. Barregard,et al.  Regulatory factors of basal F2-isoprostane formation: Population, age, gender and smoking habits in humans , 2009, Free radical research.

[24]  玉江 和義.  Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine , 2009 .

[25]  M. Tremblay,et al.  The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. , 2009, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[26]  M. Woodward,et al.  Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. , 2009, Clinical science.

[27]  P. Cuijpers,et al.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods , 2008, International journal of methods in psychiatric research.

[28]  V. Hamuryudan,et al.  Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. , 2008, Clinical biochemistry.

[29]  T. Mizoue,et al.  Body mass index and oxidative DNA damage: A longitudinal study , 2007, Cancer science.

[30]  L. Beilin,et al.  A reduction in alcohol consumption is associated with reduced plasma F2-isoprostanes and urinary 20-HETE excretion in men. , 2007, Free radical biology & medicine.

[31]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[32]  T. Funahashi,et al.  Systemic oxidative stress is associated with visceral fat accumulation and the metabolic syndrome. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[33]  A. Pilger,et al.  8-Hydroxy-2′-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposures , 2006, International archives of occupational and environmental health.

[34]  D. Giustarini,et al.  Biomarkers of oxidative damage in human disease. , 2006, Clinical chemistry.

[35]  R. Krauss,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.

[36]  A. Hamsten,et al.  Measures of Oxidized Low-Density Lipoprotein and Oxidative Stress Are Not Related and Not Elevated in Otherwise Healthy Men With the Metabolic Syndrome , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[37]  K. Tamae,et al.  Occupational and lifestyle factors and urinary 8‐hydroxydeoxyguanosine , 2005, Cancer science.

[38]  C. Lewis,et al.  Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. , 2005, Clinical chemistry.

[39]  C. Heward,et al.  Urinary excretion of three nucleic acid oxidation adducts and isoprostane F(2)alpha measured by liquid chromatography-mass spectrometry in smokers, ex-smokers, and nonsmokers. , 2003, Free radical biology & medicine.

[40]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[41]  E. Benjamin,et al.  Obesity and Systemic Oxidative Stress: Clinical Correlates of Oxidative Stress in The Framingham Study , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[42]  G. D. De Meyer,et al.  Elevated Levels of Oxidative DNA Damage and DNA Repair Enzymes in Human Atherosclerotic Plaques , 2002, Circulation.

[43]  J. Morrow,et al.  Factors associated with oxidative stress in human populations. , 2002, American journal of epidemiology.

[44]  B. Halliwell,et al.  Raised levels of F2-isoprostanes and prostaglandin F2α in different rheumatic diseases , 2001 .

[45]  Shoko Kawanami,et al.  Life Style and Urinary 8‐Hydroxydeoxyguanosine, a Marker of Oxidative DNA Damage: Effects of Exercise, Working Conditions, Meat Intake, Body Mass Index, and Smoking , 2001, Japanese journal of cancer research : Gann.

[46]  B. Halliwell,et al.  Raised levels of F(2)-isoprostanes and prostaglandin F(2alpha) in different rheumatic diseases. , 2001, Annals of the rheumatic diseases.

[47]  B. Halliwell,et al.  The steady-state levels of oxidative DNA damage and of lipid peroxidation (F2-isoprostanes) are not correlated in healthy human subjects , 2000, Free radical research.

[48]  G. FitzGerald,et al.  Alcohol-induced generation of lipid peroxidation products in humans. , 1999, The Journal of clinical investigation.

[49]  A. Tjønneland,et al.  Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. , 1992, Carcinogenesis.

[50]  S. Nishimura,et al.  Detection and identification of mutagens and carcinogens as their adducts with guanosine derivatives. , 1984, Nucleic acids research.